NTRK2 and neurodegenerative disease: We therefore hypothesized that combined BDNF and TrkB replacement would demonstrate superior efficacy compared to receptor or ligand alone and assessed this in two models of neurodegenerative disease known to be associated with reduced axonal transport (12–14).